Cargando…
Identification of Hepatic Dendritic Cells in Liver Biopsies in Patients with Metabolic Dysfunction-Associated Fatty Liver Diseas (MAFLD) and Obesity
BACKGROUND: Metabolic dysfunction-associated fatty liver disease (MAFLD) is now the term used for hepatic steatosis in patients who are overweight or obese, have type 2 diabetes mellitus (T2DM), or evidence of metabolic dysregulation. The prevalence of MAFLD among morbidly obese subjects is 65–93%....
Autores principales: | Barranco-Fragoso, Beatriz, Pal, Shreya C., Díaz-Orozco, Luis E., Dorantes-Heredia, Rita, Qi, Xingshun, Méndez-Sánchez, Nahum |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373829/ https://www.ncbi.nlm.nih.gov/pubmed/35934868 http://dx.doi.org/10.12659/MSM.937528 |
Ejemplares similares
-
A Review of the Increasing Prevalence of Metabolic-Associated Fatty Liver Disease (MAFLD) in Children and Adolescents Worldwide and in Mexico and the Implications for Public Health
por: Ramírez-Mejía, Mariana M., et al.
Publicado: (2021) -
Furthering research on MAFLD: the APASL Metabolic fAtty lIver DiseasE coNsortium (MAIDEN)
por: George, Jacob, et al.
Publicado: (2023) -
Editorial: International Consensus Recommendations to Replace the Terminology of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic-Associated Fatty Liver Disease (MAFLD)
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2021) -
Molecular Mechanisms Involved in MAFLD in Cholecystectomized Patients: A Cohort Study
por: Pal, Shreya C., et al.
Publicado: (2023) -
The Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver Disease
por: Almeda-Valdes, Paloma, et al.
Publicado: (2015)